NCT06534723: Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
- State
- Under way
- Phase
- Phase 3
- People
- 570 planned
- Started
- 20 Aug 2024
- Primary completion
- 31 Aug 2026
- Arms
- Wujia Yizhi Granules
- Results
- None posted
- 2 Aug 2024: Trial registered
- 20 Aug 2024: Trial started